Court: US District Court for District of New Jersey

Teva to be investigated by FTC, ramping up scrutiny of Orange Book listings

Antitrust challenges against pharma patent strategies continue to escalate

02 July 2024

Amgen’s Sandoz settlement latest of many biosimilar dispute successes

Californian company has been one of the most prolific litigants on both sides of BPCIA disputes

16 May 2024

Northern California, New Jersey judicial nominees advance to Senate vote

Chief IP officers with patent cases pending before these two important US district courts will want to study the patent litigation track records of Judges Eumi K Lee and Edward S Kiel

04 December 2023

The top US patent jury verdicts of 2023’s first quarter

Finesse Wireless won the most in litigation against AT&T over Nokia base stations, while DISH Networks gets the biggest defence win – overturning a $470 million jury verdict

03 April 2023

Uncovering US trade secret case trends

Docket Navigator data shows the top courts, judges, and parties of 2022 – and reveals trends in new federal trade secrets cases in the US

13 March 2023

Patent cases before US district courts drop in 2022

Docket Navigator data indicates patent filings decreased the most in Delaware and West Texas – but Eastern Texas got a slight bump

09 January 2023

Data shows New Jersey district court’s key for biopharma patent litigation

We have scoured Docket Navigator for must-know metrics on case filing trends, rulings on important motions, injunctive relief and damages awards

12 December 2022